NO870379L - Kinonderivater, fremstilling og anvendelse derav. - Google Patents

Kinonderivater, fremstilling og anvendelse derav.

Info

Publication number: NO870379L
Authority: NO; Norway
Prior art keywords: sup; agents; sub; hydrogen atom; group
Prior art date: 1986-01-30

Application number

NO870379A

Other languages

English (en)

Norwegian (no)

Other versions

NO870379D0 (no

Inventor

Shinji Terao

Kohei Nishikawa

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-01-30

Filing date

1987-01-29

Publication date

1987-07-31

1987-01-29 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

1987-01-29 Publication of NO870379D0 publication Critical patent/NO870379D0/no

1987-07-31 Publication of NO870379L publication Critical patent/NO870379L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03C—MODULATION
- H03C1/00—Amplitude modulation

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Immunology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Diabetes (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Reproductive Health (AREA)
Cardiology (AREA)
Pyridine Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Suspension Of Electric Lines Or Cables (AREA)

NO870379A 1986-01-30 1987-01-29 Kinonderivater, fremstilling og anvendelse derav. NO870379L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP1954786		1986-01-30
JP9416886		1986-04-23

Publications (2)

Publication Number	Publication Date
NO870379D0 NO870379D0 (no)	1987-01-29
NO870379L true NO870379L (no)	1987-07-31

Family

ID=26356389

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO870379A NO870379L (no)	1986-01-30	1987-01-29	Kinonderivater, fremstilling og anvendelse derav.

Country Status (16)

Country	Link
US (3)	US4851413A (da)
EP (1)	EP0234729B1 (da)
JP (1)	JPH0830061B2 (da)
KR (1)	KR870007119A (da)
CN (1)	CN87100723A (da)
AT (1)	ATE70828T1 (da)
AU (1)	AU601657B2 (da)
CA (1)	CA1285562C (da)
DE (1)	DE3775427D1 (da)
DK (1)	DK28687A (da)
FI (1)	FI870394A7 (da)
HU (1)	HU198908B (da)
IL (1)	IL81264A (da)
NO (1)	NO870379L (da)
PT (1)	PT84217B (da)
SU (1)	SU1676442A3 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE74269T1 (de) *	1987-07-29	1992-04-15	Takeda Chemical Industries Ltd	Zellproliferationsinhibitor.
JPH08768B2 (ja) *	1989-08-24	1996-01-10	武田薬品工業株式会社	神経成長因子分泌誘導剤
US5329010A (en) *	1991-03-11	1994-07-12	Eisai Co., Ltd.	Quinone derivatives
EP0560568A3 (en) *	1992-03-13	1994-06-29	Takeda Chemical Industries Ltd	Hydroquinone derivatives and intermediates for production thereof
AU657413C (en) *	1992-05-29	2007-05-03	Otsuka Pharmaceutical Co., Ltd.	Thiazole derivatives for the release of superoxide radical
US5639770A (en) *	1992-05-29	1997-06-17	Otsuka Pharmaceutical Co., Ltd.	Thiazole derivatives
WO1996004909A1 (en) *	1994-08-12	1996-02-22	Takeda Chemical Industries, Ltd.	Use of quinone and hydroquinone derivatives for the teatment of cachexia
EP0719552A3 (en) *	1994-12-26	1997-08-20	Takeda Chemical Industries Ltd	Pharmaceutical composition containing a quinone derivative or the hydroquinone thereof for the treatment of dermatitis
US6653316B1 (en) *	1999-05-19	2003-11-25	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6664255B1 (en) *	1999-05-19	2003-12-16	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US6867217B1 (en)	1999-05-19	2005-03-15	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US6458952B1 (en) *	1999-05-19	2002-10-01	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US7015230B1 (en)	1999-05-19	2006-03-21	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6750342B1 (en)	1999-05-19	2004-06-15	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6908919B2 (en) *	1999-05-19	2005-06-21	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US6906068B1 (en)	1999-05-19	2005-06-14	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants
US6716838B1 (en)	1999-05-19	2004-04-06	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
AU775373B2 (en)	1999-10-01	2004-07-29	Immunogen, Inc.	Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
WO2001068605A1 (en)	2000-03-13	2001-09-20	Pharmacia Corporation	Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
AU2001249870A1 (en)	2000-04-05	2001-10-23	Pharmacia Corporation	Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
CA2405306A1 (en) *	2000-04-05	2001-10-18	Pharmacia Corporation	Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
CA2405684A1 (en) *	2000-04-17	2001-10-25	Pharmacia Corporation	Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
US7015223B1 (en)	2000-11-20	2006-03-21	Pharmacia Corporation	Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
MXPA03004458A (es) *	2000-11-20	2005-01-25	Pharmacia Corp	Arilpiridinas y heteroarilpiridinas sustituidas utiles para inhibicion selectiva de la cascada de coagulacion.
US7119094B1 (en)	2000-11-20	2006-10-10	Warner-Lambert Company	Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
US20030236257A1 (en) *	2001-04-04	2003-12-25	South Michael S.	Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the cogulation cascade
MXPA04003167A (es) *	2001-10-03	2004-07-08	Pharmacia Corp	Compuestos heterociclicos insaturados de 6 miembros utiles para la inhibicion selectiva de la cascada de coagulacion.
US20040082585A1 (en) *	2001-10-03	2004-04-29	Pharmacia Corporation	Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
EP1438292A1 (en) *	2001-10-03	2004-07-21	Pharmacia Corporation	6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
AU2002367752A1 (en) *	2001-10-03	2003-11-17	Pharmacia Corporation	Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
AU2002340670A1 (en) *	2001-11-13	2003-05-26	Celator Technologies, Inc.	Lipid carrier compositions and methods for improved drug retention
US20040068113A1 (en) *	2001-11-20	2004-04-08	South Michael S.	Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
US6653311B1 (en)	2002-06-25	2003-11-25	Board Of Supervisors Of Louisiana State University	5-lipoxygenase inhibitors: (2-azinylamino) quinone derivatives
WO2009052376A1 (en)	2007-10-18	2009-04-23	Musc Foundation For Research Development	Methods for the diagnosis of genitourinary cancer
US8263094B2 (en) *	2008-09-23	2012-09-11	Eastman Chemical Company	Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
EP2505583A1 (en) *	2011-03-29	2012-10-03	Centre National de la Recherche Scientifique	Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents
US10189830B2 (en)	2013-03-15	2019-01-29	Bioelectron Technology Corporation	Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3929880A (en) *	1971-08-21	1975-12-30	Merck Patent Gmbh	Process for the preparation of oxocarboxylic acid amides and oxocarboxylic acids
US4201588A (en) *	1974-04-15	1980-05-06	Eastman Kodak Company	Radiation sensitive co(III)complex photoreduction element with image recording layer
US4271083A (en) *	1974-05-02	1981-06-02	Takeda Chemical Industries, Ltd.	6-Hydroxy-1,4-benzoquinone compounds
EP0003732B1 (en) *	1978-02-01	1983-10-19	The Wellcome Foundation Limited	Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
EP0004727B1 (en) *	1978-04-12	1981-08-12	Imperial Chemical Industries Plc	Blood platelet aggregation inhibitory pyridine derivatives, pharmaceutical compositions thereof, and processes for their manufacture
US4393075A (en) *	1980-04-14	1983-07-12	Takeda Chemical Industries, Ltd.	Quinone compounds and their use in suppressing the production of SRS-A in mammals
JPS58177934A (ja) *	1982-04-13	1983-10-18	Takeda Chem Ind Ltd	ベンゾキノン誘導体
JPS5910541A (ja) *	1982-07-09	1984-01-20	Takeda Chem Ind Ltd	キノン化合物
MX9203040A (es) *	1984-08-01	1992-07-31	Takeda Chemical Industries Ltd	Derivados de quinona y composicion farmaceutica que los contiene.

1987
- 1987-01-14 IL IL81264A patent/IL81264A/xx not_active IP Right Cessation
- 1987-01-15 CA CA000527381A patent/CA1285562C/en not_active Expired - Lifetime
- 1987-01-16 US US07/004,138 patent/US4851413A/en not_active Expired - Lifetime
- 1987-01-20 DK DK028687A patent/DK28687A/da not_active Application Discontinuation
- 1987-01-22 AU AU67933/87A patent/AU601657B2/en not_active Ceased
- 1987-01-23 DE DE8787300581T patent/DE3775427D1/de not_active Expired - Fee Related
- 1987-01-23 AT AT87300581T patent/ATE70828T1/de not_active IP Right Cessation
- 1987-01-23 EP EP19870300581 patent/EP0234729B1/en not_active Expired - Lifetime
- 1987-01-27 KR KR870000637A patent/KR870007119A/ko not_active Abandoned
- 1987-01-29 FI FI870394A patent/FI870394A7/fi not_active Application Discontinuation
- 1987-01-29 SU SU874028912A patent/SU1676442A3/ru active
- 1987-01-29 NO NO870379A patent/NO870379L/no unknown
- 1987-01-29 PT PT84217A patent/PT84217B/pt not_active IP Right Cessation
- 1987-01-30 JP JP62021516A patent/JPH0830061B2/ja not_active Expired - Lifetime
- 1987-01-30 CN CN198787100723A patent/CN87100723A/zh active Pending
- 1987-01-30 HU HU87310A patent/HU198908B/hu not_active IP Right Cessation
1989
- 1989-04-25 US US07/343,142 patent/US4985447A/en not_active Expired - Fee Related
1990
- 1990-10-19 US US07/600,149 patent/US5106858A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK28687D0 (da)	1987-01-20
CA1285562C (en)	1991-07-02
PT84217A (en)	1987-02-01
KR870007119A (ko)	1987-08-14
FI870394A7 (fi)	1987-07-31
DE3775427D1 (de)	1992-02-06
EP0234729A2 (en)	1987-09-02
HUT44504A (en)	1988-03-28
IL81264A (en)	1990-11-05
DK28687A (da)	1987-07-31
IL81264A0 (en)	1987-08-31
NO870379D0 (no)	1987-01-29
JPH0830061B2 (ja)	1996-03-27
EP0234729B1 (en)	1991-12-27
AU601657B2 (en)	1990-09-13
CN87100723A (zh)	1987-09-16
SU1676442A3 (ru)	1991-09-07
JPS6345257A (ja)	1988-02-26
ATE70828T1 (de)	1992-01-15
AU6793387A (en)	1987-08-06
US4985447A (en)	1991-01-15
US5106858A (en)	1992-04-21
PT84217B (pt)	1989-09-14
EP0234729A3 (en)	1988-01-27
HU198908B (en)	1989-12-28
FI870394A0 (fi)	1987-01-29
US4851413A (en)	1989-07-25

Publication	Publication Date	Title
NO870379D0 (no)	1987-01-29	Kinonderivater, fremstilling og anvendelse derav.
ES8704870A1 (es)	1987-04-16	Un procedimiento para preparar derivados de quiniona.
GB1511366A (en)	1978-05-17	Aliphatic carboxylic acid esters of vitamin e and process for preparation thereof
CZ87395A3 (en)	1995-10-18	Derivatives of 25-carboxylic acid in a series of d vitamins, process of their preparation, intermediates employed in this process, as well as their use in the preparation of medicaments
ATE63913T1 (de)	1991-06-15	Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
ES448396A1 (es)	1977-09-16	Procedimiento para la obtencion de esteres de alcoxialquil- hidropiridinas.
FI811824L (fi)	1981-12-17	Framstaellning av 2-keto-d-glukonsyra och vaeteperoxid
EP0342665A3 (en)	1990-08-16	Physiologically active substance tan-931, its derivatives, their production and use
ES8102563A1 (es)	1981-01-16	Procedimiento para la preparacion de nuevas sustancias analogas de prostaciclina
GB1480025A (en)	1977-07-20	Derivatives of pyrazolo-(4,3-c)pyridimes
FR2396014A1 (fr)	1979-01-26	Esters d'acides silylacetyleniques et leurs utilisations therapeutiques, notamment comme antibacteriens
ZA811791B (en)	1982-06-30	Quinuclindinic esters and derivatives of phenoxycarboxylic acids,a process for the preparation thereof,and related pharmaceutical compositions
GB1321692A (en)	1973-06-27	Dihydro-3-piperidyl-2 3h-furanone derivatives
JPS5695188A (en)	1981-08-01	Theophyllin derivative and its production
ES482469A1 (es)	1980-04-01	Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2) sustituidas.
GB1510092A (en)	1978-05-10	Derivatives of vincaminic acid hydrazide
IE43256L (en)	1977-01-04	Tetrahydrofuroquinoline-7-carboxylic acid derivatives
JPS5265251A (en)	1977-05-30	Synthesis of prostaglandin derivatives
GB1397807A (en)	1975-06-18	Process for preparing alpha-keto esters
JPS5543027A (en)	1980-03-26	2-pyridyl-1-phthalazone derivative
JPS51115481A (en)	1976-10-12	Process for preparation of (3,4-dihydro-6-carbostyril)carboxylic and e ster derivatives
DE3469734D1 (en)	1988-04-14	Biphenylylalkanoic acid derivatives, methods of preparation and pharmaceutical compositions therefrom
ES8307782A1 (es)	1983-08-01	Procedimiento para la preparacion de un nuevo derivado perteneciente a la familia de los 3-amino-1-heteroariloxi-2-propanoles.